Leading the Way in Life Science Technologies

GEN Exclusives

More »

Related to Rosetta's miRNA-Based Cancer Tests Break Into European Market through Distribution Deal with AXA

  • Page 1 of 1 (7 items) 1 

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »